← Fresenius Medical Care AG FMS
Market Price
$23.77
Market Cap
$12.58B
P/E Ratio
N/A
Revenue (FY 2025)
↑1.5% YoY
$19.63B
3-Yr CAGR: 0.4%
Net Income
↑4.9% YoY
$212.90M
Net Margin: 1.1%
Free Cash Flow
↓-34.6% YoY
-$830.52M
FCF Yield: -6.60%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
N/A
ROA: 0.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (FMS)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $16,569.7M | — | $5,615.9M | $276.1M | — | — | — | $30.3M | — | — |
| FY 2017 | $17,783.6M | +7.3% | $6,003.7M | $274.7M | -0.5% | — | — | $35.5M | $-908.9M | — |
| FY 2018 | $16,546.9M | -7.0% | $5,154.7M | $243.7M | -11.3% | — | — | $56.8M | — | — |
| FY 2019 | $17,476.6M | +5.6% | $5,395.9M | $238.9M | -2.0% | — | — | $49.5M | $-1,075.3M | — |
| FY 2020 | $17,859.1M | +2.2% | $5,537.4M | $271.5M | +13.6% | — | — | $42.0M | — | — |
| FY 2021 | $17,618.7M | -1.3% | $5,077.0M | $249.7M | -8.0% | — | — | $73.2M | — | — |
| FY 2022 | $19,398.0M | +10.1% | $5,310.3M | $220.9M | -11.5% | — | — | $67.7M | $-620.1M | — |
| FY 2023 | $19,453.6M | +0.3% | $4,925.0M | $233.5M | +5.7% | — | — | $88.2M | $-580.2M | +6.4% |
| FY 2024 | $19,335.9M | -0.6% | $4,756.7M | $203.0M | -13.1% | — | — | $68.1M | $-617.2M | -6.4% |
| FY 2025 | $19,627.6M | +1.5% | $5,028.9M | $212.9M | +4.9% | — | — | $68.2M | $-830.5M | -34.6% |
Valuation
Market Price
$23.77
Market Cap
$12.58B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
N/A
FCF Yield
-6.60%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
25.62%
Operating Margin
9.31%
Net Margin
1.08%
Return on Equity (ROE)
N/A
Return on Assets (ROA)
0.69%
Asset Turnover
0.63x
Revenue 3-Yr CAGR
0.39%
Financial Health & Liquidity
Current Ratio
0.90
Cash Ratio
N/A
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
N/A
Total Debt
N/A
Book Value / Share
N/A
Cash Flow Efficiency
Operating Cash Flow
$68.16M
Capital Expenditures (CapEx)
$898.67M
Free Cash Flow
-$830.52M
OCF / Revenue
0.35%
FCF / Revenue
-4.23%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
N/A
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$31.00B
Total Liabilities
$16.72B
Stockholders' Equity
N/A
Current Assets
$126.20M
Current Liabilities
$139.59M